Europe — EMA
Palonosetron Juta Pharma
Palonosetron, the active ingredient in Palonosetron Juta Pharma, the active ingredient in Palonosetron Juta Pharma, is a 5-HT3 receptor antagonist presented as a 0.075 mg/1 ml solution for intravenous use.
Request sourcing
What is Palonosetron?
Palonosetron, the active ingredient in Palonosetron Juta Pharma, the active ingredient in Palonosetron Juta Pharma, is a 5-HT3 receptor antagonist presented as a 0.075 mg/1 ml solution for intravenous use. It treats and prevents chemotherapy‑induced nausea and vomiting in adult patients.
GNH USA supplies Palonosetron Juta Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres and pharmacies worldwide.
What is Palonosetron used for?
Palonosetron is a selective 5‑HT3 receptor antagonist that acts on the emetic pathway of the central nervous system and the gastrointestinal GI tract. - Chemotherapy‑induced nausea and N/V : Pre‑‑ … … … .... etc…. - ... ... ... .... .... .... ... … … ...
What are the side effects of Palonosetron?
...
